This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 26/7/1572    most recent 01.ATV.0000225700.43836.aev1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Valenta, D. T. Articles by Desrumaux, C. M. Search for Related Content PubMed PubMed Citation Articles by Valenta, D. T. Articles by Desrumaux, C. M. Related Collections Animal models of human disease Risk Factors Lipid and lipoprotein metabolism Oxidant stress

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1572.)
© 2006 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Atheroprotective Potential of Macrophage-Derived Phospholipid Transfer Protein in Low-Density Lipoprotein Receptor-Deficient Mice Is Overcome by Apolipoprotein AI Overexpression

David T. Valenta; Nicolas Ogier; Gary Bradshaw; Audrey S. Black; David J. Bonnet; Laurent Lagrost; Linda K. Curtiss; Catherine M. Desrumaux

From the Department of Immunology (D.T.V., G.B., A.S.B., D.J.B., L.K.C.), The Scripps Research Institute, La Jolla, Calif; and INSERM U498 (N.O., L.L., C.M.D.), Faculté de Médecine, Dijon Cedex, France.

Correspondence to Linda K. Curtiss, Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037. E-mail lcurtiss{at}scripps.edu

Objective— Using bone marrow transplantation, we assessed the impact of macrophage-derived phospholipid transfer protein (PLTP) on lesion development in hypercholesterolemic mice that expressed either normal levels of mouse apolipoprotein AI (apoAI) or elevated levels of only human apoAI.

Methods and Results— Bone marrow transplantations were performed in low-density lipoprotein receptor-deficient mice (LDLr–/–) that expressed either normal levels of mouse apoAI (msapoAI) or high levels of only human apoAI (msapoAI–/–, LDLr–/–, huapoAITg). Mice were lethally irradiated, reconstituted with either PLTP-expressing or PLTP-deficient bone marrow cells, and fed a high-fat diet over 16 weeks. Macrophage PLTP deficiency increased atherosclerosis in LDLr–/– mice with minimal changes in total plasma cholesterol levels. In contrast, the extent of atherosclerosis in msapoAI–/–, LDLr–/–, huapoAITg mice was not significantly different between groups that had received PLTP–/– or PLTP+/+ bone marrow. In vitro studies indicated that PLTP deficiency led to a significant decrease in -tocopherol content and increased oxidative stress in bone marrow cells.

Conclusions— Our observations suggest an atheroprotective role of macrophage-derived PLTP in mice with normal apoAI plasma levels. The atheroprotective properties of macrophage-derived PLTP were not observable in the presence of elevated plasma concentrations of apoAI.

Using bone marrow transplantation, macrophage-derived PLTP was shown to be atheroprotective in hypercholesterolemic mice fed a high-fat diet. This effect was only observed in mice with normal apoAI plasma levels and not in transgenic mice with elevated human apoAI plasma levels.

Key Words: phospholipid transfer protein • apolipoprotein AI • atherosclerosis • transgenic mice • bone marrow transplant

This article has been cited by other articles:

				N. J. Hime, A. S. Black, J. J. Bulgrien, and L. K. Curtiss Leukocyte-derived hepatic lipase increases HDL and decreases en face aortic atherosclerosis in LDLr-/- mice expressing CETP J. Lipid Res., October 1, 2008; 49(10): 2113 - 2123. [Abstract] [Full Text] [PDF]

				J. F. Oram, G. Wolfbauer, C. Tang, W. S. Davidson, and J. J. Albers An Amphipathic Helical Region of the N-terminal Barrel of Phospholipid Transfer Protein Is Critical for ABCA1-dependent Cholesterol Efflux J. Biol. Chem., April 25, 2008; 283(17): 11541 - 11549. [Abstract] [Full Text] [PDF]

				L. Shelly, L. Royer, T. Sand, H. Jensen, and Y. Luo Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice J. Lipid Res., April 1, 2008; 49(4): 773 - 781. [Abstract] [Full Text] [PDF]

				M. Lee-Rueckert, R. Vikstedt, J. Metso, M. Jauhiainen, and P. T. Kovanen Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast cell chymase J. Lipid Res., February 1, 2008; 49(2): 358 - 368. [Abstract] [Full Text] [PDF]

				G. H. Tomkin Targets for Intervention in Dyslipidemia in Diabetes Diabetes Care, February 1, 2008; 31(Supplement_2): S241 - S248. [Abstract] [Full Text] [PDF]

				D. T. Valenta, J. J. Bulgrien, D. J. Bonnet, and L. K. Curtiss Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency J. Lipid Res., January 1, 2008; 49(1): 24 - 32. [Abstract] [Full Text] [PDF]

				N. Ogier, A. Klein, V. Deckert, A. Athias, G. Bessede, N. Le Guern, L. Lagrost, and C. Desrumaux Cholesterol Accumulation Is Increased in Macrophages of Phospholipid Transfer Protein-Deficient Mice: Normalization by Dietary Alpha-Tocopherol Supplementation Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2407 - 2412. [Abstract] [Full Text] [PDF]

				D. Yan, M. Jauhiainen, R. B. Hildebrand, K. Willems van Dijk, T. J.C. Van Berkel, C. Ehnholm, M. Van Eck, and V. M. Olkkonen Expression of Human OSBP-Related Protein 1L in Macrophages Enhances Atherosclerotic Lesion Development in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1618 - 1624. [Abstract] [Full Text] [PDF]

				A. Wehinger, I. Tancevski, W. Schgoer, P. Eller, K. Hochegger, M. Morak, A. Hermetter, A. Ritsch, J. R. Patsch, and B. Foeger Phospholipid Transfer Protein Augments Apoptosis in THP-1-Derived Macrophages Induced by Lipolyzed Hypertriglyceridemic Plasma Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 908 - 915. [Abstract] [Full Text] [PDF]

				R. Vikstedt, D. Ye, J. Metso, R. B. Hildebrand, T. J.C. Van Berkel, C. Ehnholm, M. Jauhiainen, and M. Van Eck Macrophage Phospholipid Transfer Protein Contributes Significantly to Total Plasma Phospholipid Transfer Activity and Its Deficiency Leads to Diminished Atherosclerotic Lesion Development Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 578 - 586. [Abstract] [Full Text] [PDF]

				R. Liu, M. R. Hojjati, C. M. Devlin, I. H. Hansen, and X.-C. Jiang Macrophage Phospholipid Transfer Protein Deficiency and ApoE Secretion: Impact on Mouse Plasma Cholesterol Levels and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 190 - 196. [Abstract] [Full Text] [PDF]

				A. Baldan, L. Pei, R. Lee, P. Tarr, R. K. Tangirala, M. M. Weinstein, J. Frank, A. C. Li, P. Tontonoz, and P. A. Edwards Impaired Development of Atherosclerosis in Hyperlipidemic Ldlr-/- and ApoE-/- Mice Transplanted With Abcg1-/- Bone Marrow Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2301 - 2307. [Abstract] [Full Text] [PDF]